Status:
RECRUITING
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
Lead Sponsor:
Aloha Vision Consultants
Collaborating Sponsors:
Sengi
Conditions:
Cataract
Eligibility:
All Genders
Brief Summary
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assess...
Eligibility Criteria
Inclusion
- Adult patients undergoing age-related cataract surgery.
- Planned use of the Catalys Precision Laser System.
- Planned implantation of TECNIS intraocular lenses (IOLs).
Exclusion
- • Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).
Key Trial Info
Start Date :
October 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07176416
Start Date
October 3 2025
End Date
October 1 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aloha Vision Consultants
‘Aiea, Hawaii, United States, 96701